Found 0 matching trials
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes N/A This is an ongoing evaluation of subjects exposed to ibrexafungerp while pr...
Show More Learn More & Join Trial
Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp PHASE1 This is a pharmacokinetic evaluation of lactating women after receiving two...
Show More Location
Woodland Research Northwest (WRN)
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment PHASE3 This is a multicenter, open label, non-comparator, single arm study to eval...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) PHASE3 This is a multicenter, open-label, non-comparator, single-arm study to eval...
Show More Learn More & Join Trial
Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis PHASE2 This is a multicenter, randomized, double-blind, double-dummy, active-contr...
Show More Location
UAB Personal Health Clinic
Learn More & Join Trial
Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects PHASE1 This is an Open-Label, Randomized, Two-Period, Crossover Study to Evaluate ...
Show More Location
Scientia Clinical Research Limited Bright Building
Learn More & Join Trial
Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis PHASE2 This is a randomized, multicenter, evaluator blinded study to evaluate the ...
Show More Location
Hospital Dr. Francisco E. Moscoso Puello
Learn More & Join Trial